SARS-CoV-2 Virology, Immunology and Clinical Management
This community investigates the molecular biology, immune response, and clinical treatment of SARS-CoV-2 and other acute respiratory viruses.
The research focuses heavily on the structural characterization of the viral spike protein and main protease, often using electron microscopy and molecular docking to understand viral entry and replication. A significant portion of the work addresses the clinical management of severe acute respiratory syndrome, including the use of remdesivir and the monitoring of oxygen saturation in patients. The community also examines the role of heparan sulfate and the endothelial glycocalyx in viral pathogenesis, alongside studies on vaccine design and immune evasion by variants such as Omicron.
The largest share of the community's output is found in oxygen research, accounting for 0.1% of all oxygen research, with 462 papers in this group. Sulfur research follows with 451 papers, representing 0.2% of sulfur research.
The community comprises 13,611 papers, publishing most frequently in bioRxiv, Dermatologic Therapy, and Signal Transduction and Targeted Therapy.
Recent work continues to focus on the structural dynamics of SARS-CoV-2 variants, including loss-of-function mutations in the spike protein, and the interaction of heparan sulfate with viral signaling pathways.